Literature DB >> 24953529

Different methylation profiles between intestinal and diffuse sporadic gastric carcinogenesis.

Misuk Yang1, Hyun-Soo Kim2, Mee Yon Cho3.   

Abstract

OBJECTIVE: Gastric cancer (GC) is histologically classified into intestinal type and diffuse type, and diffuse type cancer can be further subdivided into poorly differentiated carcinoma (PDC) and signet ring cell carcinoma (SRCC). Recent evidence suggests that early SRCC is an initial, differentiated form of diffuse GC that may evolve into PDC. This study aimed at identifying the molecular features of epigenetic methylation changes in histologic differentiation status of GC.
METHODS: Included in this study are 149 samples of paraffin-embedded tissues and 115 fresh endoscopically biopsied tissues. Multiple paraffin tissues involving normal (n=22), dysplasias (GDs, n=39), differentiated cancers (DCs, n=35), PDCs (n=33) and SRCCs (n=20) were included as an experimental group. For the validation group, endoscopically biopsied tissues of DCs (n=50), PDCs (n=31), and SRCs (n=34) were analyzed. DNAs, isolated from each group were analyzed to determine the methylation status of 6 genes (GDNF, RORA, MINT25, KLF7, CDH1, LINE-1) using pyrosequencing.
RESULTS: LINE-1 was hypomethylated in GCs compared to normal and GD. GDNF, RORA and MINT25 were more hypermethylated in intestinal type GCs than those of diffuse type GCs, whereas CDH1 showed opposite patterns of methylation. Among diffuse type GCs, SRCCs showed lower level of methylation for GDNF, RORA, MINT25 and KLF7, and higher level for CDH1 compared to PDCs.
CONCLUSIONS: In conclusion, intestinal type of GCs shows different epigenetic methylation profiles compared to the diffuse one. Moreover, SRCCs have different methylation profiles compared with PDCs, suggesting a unique molecular pathway in the gastric carcinogenesis.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24953529     DOI: 10.1016/j.clinre.2014.03.017

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  6 in total

1.  LINE-1 hypomethylation is not a common event in preneoplastic stages of gastric carcinogenesis.

Authors:  Juozas Kupcinskas; Ruta Steponaitiene; Cosima Langner; Giedre Smailyte; Jurgita Skieceviciene; Limas Kupcinskas; Peter Malfertheiner; Alexander Link
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

2.  LINE-1 hypomethylation is inversely correlated with UHRF1 overexpression in gastric cancer.

Authors:  Jang Hee Hong; Eun-Heui Jin; Soyeon Kim; Kyu-Sang Song; Jae Kyu Sung
Journal:  Oncol Lett       Date:  2018-02-27       Impact factor: 2.967

3.  Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer.

Authors:  Raefa Abou Khouzam; Chiara Molinari; Samanta Salvi; Monica Marabelli; Valeria Molinaro; Donata Orioli; Luca Saragoni; Paolo Morgagni; Daniele Calistri; Guglielmina Nadia Ranzani
Journal:  Oncotarget       Date:  2017-03-21

4.  Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis-Deepening Heterogeneity for a Personalized Therapy.

Authors:  Gloria Ravegnini; Bruno Fosso; Viola Di Saverio; Giulia Sammarini; Federica Zanotti; Giulio Rossi; Monica Ricci; Federica D'Amico; Giorgia Valori; Antonella Ioli; Silvia Turroni; Patrizia Brigidi; Patrizia Hrelia; Sabrina Angelini
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

Review 5.  Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.

Authors:  Magdalena Cisło; Agata Anna Filip; George Johan Arnold Offerhaus; Bogumiła Ciseł; Karol Rawicz-Pruszyński; Małgorzata Skierucha; Wojciech Piotr Polkowski
Journal:  Oncotarget       Date:  2018-04-10

6.  DNA methylation of CpG sites in the chicken KLF7 promoter and Exon 2 in association with mRNA expression in abdominal adipose tissue and blood metabolic indicators.

Authors:  Zhiwei Zhang; Cunxi Nie; Yuechan Chen; Yanzhe Dong; Tao Lin
Journal:  BMC Genet       Date:  2020-10-14       Impact factor: 2.797

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.